Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,973 | -1,918 | -1,338 | -641 | -3,024 |
| Accounts receivable | N/A | N/A | N/A | 38 | 1 |
| Other Working Capital | 738 | 174 | 2 | -119 | -598 |
| Other Operating Activity | 422 | 361 | 310 | 122 | 542 |
| Operating Cash Flow | $-1,813 | $-1,383 | $-1,026 | $-600 | $-3,079 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -525 | -525 | -525 | N/A | N/A |
| Other Investing Activity | 175 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-350 | $-525 | $-525 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 372 | 368 | 230 | N/A | N/A |
| Debt Issued | 625 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | N/A | 2,021 |
| Other Financing Activity | -162 | -6 | 0 | 0 | -539 |
| Financing Cash Flow | $835 | $362 | $230 | $N/A | $1,482 |
| Beginning Cash Position | 1,727 | 1,727 | 1,727 | 1,727 | 3,324 |
| End Cash Position | 399 | 181 | 406 | 1,127 | 1,727 |
| Net Cash Flow | $-1,328 | $-1,546 | $-1,321 | $-600 | $-1,597 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,813 | -1,383 | -1,026 | -600 | -3,079 |
| Free Cash Flow | -1,813 | -1,383 | -1,026 | -600 | -3,079 |